Unleash Your LIMS Potential By Unleashing The Power Of Your Data
According to research revealed earlier this year, “the global LIMS (Laboratory Information Management Systems) market is expected to reach USD $1,155.67 million by 2025, from USD $650.7 million in 2017.” This predicts a CAGR (Compound Annual Growth Rate) of 7.7% in the forecast period.
Technology is undoubtedly growing at an exponential rate and the organizations leveraging it are gaining a visible competitive edge. Increasingly, LIMS are becoming seen as vital tools in managing, capturing and sharing sample centric test data whilst ensuring compliance to a given protocol.
But… there’s a catch.
LIMS, which are typically sample-result focused, can’t provide end-to-end workflow solutions in pharmaceutical R&D operations, meaning they often sit isolated from other laboratory technologies – leaving your data in a silo. And yet, by leveraging the functionality of a LIMS, organizations can transform their approaches to regulatory compliance and process automation, leading to increased productivity.
So, how can organizations get the ‘best of both worlds’?
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.